These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15162891)

  • 1. Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects.
    Seligman PA; Dahl NV; Strobos J; Kimko HC; Schleicher RB; Jones M; Ducharme MP
    Pharmacotherapy; 2004 May; 24(5):574-83. PubMed ID: 15162891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
    Warady BA; Seligman PA; Dahl NV
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1140-6. PubMed ID: 17942782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
    Folkert VW; Michael B; Agarwal R; Coyne DW; Dahl N; Myirski P; Warnock DG;
    Am J Kidney Dis; 2003 Mar; 41(3):651-7. PubMed ID: 12612989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
    Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel population pharmacokinetic method compared to the standard noncompartmental approach to assess bioequivalence of iron gluconate formulations.
    Seng Yue C; Gallicano K; Labbé L; Ducharme MP
    J Pharm Pharm Sci; 2013; 16(3):424-40. PubMed ID: 24021291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
    Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease.
    Panesar A; Agarwal R
    Am J Kidney Dis; 2002 Nov; 40(5):924-31. PubMed ID: 12407636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
    Coyne DW; Adkinson NF; Nissenson AR; Fishbane S; Agarwal R; Eschbach JW; Michael B; Folkert V; Batlle D; Trout JR; Dahl N; Myirski P; Strobos J; Warnock DG;
    Kidney Int; 2003 Jan; 63(1):217-24. PubMed ID: 12472786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron replacement with sodium ferric gluconate complex in sucrose for iron deficiency anemia in adults.
    Kane RC
    Curr Ther Res Clin Exp; 2003 Apr; 64(4):263-8. PubMed ID: 24944373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safety.
    Michael B; Coyne DW; Folkert VW; Dahl NV; Warnock DG;
    Nephrol Dial Transplant; 2004 Jun; 19(6):1576-80. PubMed ID: 15034152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium ferric gluconate complex maintenance therapy in children on hemodialysis.
    Warady BA; Zobrist RH; Finan E;
    Pediatr Nephrol; 2006 Apr; 21(4):553-60. PubMed ID: 16520948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
    Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
    Danielson BG; Salmonson T; Derendorf H; Geisser P
    Arzneimittelforschung; 1996 Jun; 46(6):615-21. PubMed ID: 8767353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Effectiveness of an Accelerated Intravenous Iron Administration Protocol in Hospitalized Patients With Heart Failure.
    Eche IM; Owen KL; Eche IJ; Patel P; Sabe M
    J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):365-370. PubMed ID: 33563034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Ferric Pyrophosphate Citrate, a Novel Iron Salt, Administered Intravenously to Healthy Volunteers.
    Pratt RD; Swinkels DW; Ikizler TA; Gupta A
    J Clin Pharmacol; 2017 Mar; 57(3):312-320. PubMed ID: 27557937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
    Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agents.
    Preusser LC; Fryer RM; Gerhardt A; Hu Y; Delgado-Herrera L; Melnick JZ; Williams LA; Cox BF; Reinhart GA
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1020-6. PubMed ID: 16445566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
    Yorgin PD; Belson A; Sarwal M; Alexander SR
    Pediatr Nephrol; 2000 Dec; 15(3-4):171-5. PubMed ID: 11149105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.